Friday, October 25, 2024

No More Delays: Accelerating Therapy Starts by Embedding Hub Services in Provider Workflows

Today’s guest post comes from Shabbir Ahmed, Chief Commercial Officer at CareMetx.

Shabbir explains the barriers that providers face when dealing with branded portals for multiple products. He then maintains that patients can access new therapies more quickly when the manufacturer relies on a brand-agnostic hub connected to a large network of providers and integrated with the systems those providers use daily.

To learn more, download CareMetx’s new 2024 Patient Services ReportRevealing Manufacturer Priorities: Patients Naturally Take Center Stage.

Read on for Shabbir’s insights.

No More Delays: Accelerating Therapy Starts by Embedding Hub Services in Provider Workflows
By Shabbir Ahmed, Chief Commercial Officer, CareMetx

Every pharmaceutical brand wants to launch a game-changing therapy. But without a fast, seamless process to get patients started on treatment, even the most effective drug can fail to reach those who need it most. Time to therapy is critical to improving health outcomes, and manufacturers must arm providers with the tools to cut through administrative barriers and accelerate access.

ELIMINATE THE ROADBLOCKS

Today’s healthcare landscape is more competitive than ever. Manufacturers aren’t just looking to release safe and effective products—they want to help the greatest number of patients who need these therapies and ensure they obtain them as fast as possible. But all too often, outdated, fragmented processes bog down the path to therapy initiation. And this impacts everyone: patients, providers, and ultimately, the manufacturers themselves.

Providers are overwhelmed by juggling multiple systems, re-entering data, and navigating branded portals. A national survey shows 80% of providers avoid prescribing certain therapies due to these headaches, delaying critical patient care.

BREAKING FREE FROM THE BRANDED BOTTLENECK

Manufacturers clinging to branded portals as the primary interaction with providers inadvertently create obstacles in the process. Providers don’t have the time to manage multiple logins and workflows, often abandoning the portal for easier-to-access options.

Forward-thinking manufacturers are gaining an edge by embracing a brand-agnostic, provider-centric approach. Instead of forcing providers to come to them, they integrate patient access services directly into the systems providers use daily. This brings hub services directly to the point of care.

SEAMLESS INTEGRATION, FASTER THERAPY STARTS

So, how does this work? Two components are essential: First, the hub platform must integrate with the provider’s existing practice management or electronic medical records (EMR) system. Second, data must flow smoothly across the healthcare ecosystem to ensure fast, accurate information exchange.

CareMetx does exactly that. By embedding patient enrollment, benefit verification, and prior authorization into the provider’s workflow, we cut down the typical seven-step process to just two or three. Providers no longer need to re-enter data—they can pull it directly from their systems, making the process faster and more accurate.

This integration isn’t just faster—it’s scalable. CareMetx uses healthcare-specific interoperability standards, streamlining integration across practices, speeding up access and minimizing unnecessary costs.

THE POWER OF NETWORKED PROVIDERS

When manufacturers partner with a hub that offers this level of seamless integration, they’re not just simplifying therapy initiation—they’re transforming the patient journey. Providers initiate therapy faster, with fewer administrative hurdles, improving patient outcomes.

For manufacturers, the benefits are clear: They reach more patients by eliminating access barriers and gain real-time visibility into the therapy initiation process, optimizing access programs and ensuring therapies reach patients faster.

By embedding hub services directly into provider workflows, manufacturers reduce enrollment time by 80%, getting patients started on life-saving therapies sooner. This isn’t just an incremental improvement—it’s a game changer.

THE VALUE OF A CONNECTED PROVIDER NETWORK

Partnering with a hub that already has relationships with sizable specialty patient populations, through a strong network of connected providers, is key to success. That’s one reason CareMetx acquired industry pioneer PX Technology in April, after collaborating with them for five years.

The PX Connect platform allows manufacturers to tap into a network spanning multiple therapeutic areas, helping them reach providers faster and with greater precision. This unrivaled network is 1,900 providers strong (and growing), integrates with 27+ patient management or EMR systems, and processes enrollments in three minutes or less with 98% accuracy. With over 636,000 enrollments processed to date and nearly 120,000 provider hours saved, it’s no wonder providers tell us that using hub services embedded in their workflow is the preferred way to work.

As one practice commented, “PX has helped our company enroll patients with the branded drug programs, which was a very challenging process previously. PX Connect has made enrollments extremely simple for our staff and patients of all ages.” It’s also the best way to ensure the right patients get the right therapies at the right time, improving outcomes for all.

A SMARTER PATH TO PATIENT CARE

As new therapies come to market, manufacturers face the challenge of getting patients on therapy quickly and efficiently. Those who adopt a provider-centric, brand-agnostic approach will be the ones who succeed. Embedding hub services into provider workflows eliminates access barriers, reduces administrative burdens, and accelerates time to therapy.

The 2024 Patient Services Report offers deeper insights into how improving the provider experience drives better outcomes. Download the full report to discover how CareMetx is transforming patient access services—and how we can help your brand get therapies to patients faster.


The content of Sponsored Posts does not necessarily reflect the views of HMP Omnimedia, LLC, Drug Channels Institute, its parent company, or any of its employees. To find out how you can publish a guest post on Drug Channels, please contact Paula Fein (paula@DrugChannels.net).

No comments:

Post a Comment